SQUAWK/NEWS
Account
Theme
Account
Menu
Live News GEOPOLITICS FLASH H impact

Israeli dermatology firm Sol-Gel's Q3 net loss narrows on lower R&D expenses

Israeli dermatology firm Sol-Gel's Q3 net loss narrows on lower R&D expenses Overview Israel dermato

MDWDPLXSGMTSLGL

Related stories